ERIG Meeting 14 January: talk by Dr Alison Green
Dr Alison Green is a Reader at the National Creutzfeldt Jakob Disease Research and Surveillance Unit in the University of Edinburgh. She has kindly agreed to give a talk on…
Read article
Research news
Diabetes drug slows experimental Parkinson’s disease progression, human trials to begin next year
A new investigational drug, MSDC-0160, originally developed for type 2 diabetes is being readied for human clinical trials in search of the world’s first treatment to impede the progression of…
First clinical trial of CDNF in Parkinson’s announced
Herantis Pharma, a Finnish pharmaceutical company, has announced the first clinical trial of a new treatment for Parkinson’s. The study, due to start next year, will use a state of…
Why Ohsumi’s Nobel Prize is important for Parkinson’s
The 2016 Nobel Prize in Physiology or Medicine has been awarded to Japanese biologist, Yoshinori Ohsumi, for his work on how cells dispose of and recycle their waste – a…
New treatment strategy
Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal’s brain — and a way…
Vaccine for Parkinson’s Reports Positive Results
The Michael J Fox Foundation reports that new study results from Austrian biotech AFFiRiS support continued development of its vaccine against the key Parkinson’s protein alpha-synuclein. Today the company announced…